Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.
Yaghy A, Lee AY, Keane PA, Keenan TDL, Mendonca LSM, Lee CS, Cairns AM, Carroll J, Chen H, Clark J, Cukras CA, de Sisternes L, Domalpally A, Durbin MK, Goetz KE, Grassmann F, Haines JL, Honda N, Hu ZJ, Mody C, Orozco LD, Owsley C, Poor S, Reisman C, Ribeiro R, Sadda SR, Sivaprasad S, Staurenghi G, Ting DS, Tumminia SJ, Zalunardo L, Waheed NK. Yaghy A, et al. Among authors: carroll j. Exp Eye Res. 2022 Jul;220:109092. doi: 10.1016/j.exer.2022.109092. Epub 2022 May 4. Exp Eye Res. 2022. PMID: 35525297 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36150545
Focus on molecules: the cone opsins.
Carroll J. Carroll J. Exp Eye Res. 2008 Jun;86(6):865-6. doi: 10.1016/j.exer.2007.09.004. Epub 2007 Sep 19. Exp Eye Res. 2008. PMID: 17981267 Review. No abstract available.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Pupillary Dilation in Research: More than Meets the Eye.
Szpernal J, Bachman Groth JA, Wynne N, Williams V, Spellecy R, Thuruthumaly C, Carroll J. Szpernal J, et al. Among authors: carroll j. Curr Eye Res. 2022 Jul;47(7):965-977. doi: 10.1080/02713683.2022.2053723. Epub 2022 May 2. Curr Eye Res. 2022. PMID: 35499263 Free PMC article.
Fine central macular dots associated with childhood-onset Stargardt Disease.
Fujinami K, Singh R, Carroll J, Zernant J, Allikmets R, Michaelides M, Moore AT. Fujinami K, et al. Among authors: carroll j. Acta Ophthalmol. 2014 Mar;92(2):e157-9. doi: 10.1111/aos.12259. Epub 2013 Sep 11. Acta Ophthalmol. 2014. PMID: 24020726 Free article. No abstract available.
3,656 results